Direct Impact SDG: 3. Good Health and Well-being

The production of local biotechnological medicine

Health Care
Biotechnology and Pharmaceuticals

Expected Impact

Investments in biotechnology medicine production will increase the value added from medicine and make essential pharmaceuticals more readily accessible for Turkish patients.

Indicative Return

Investment Timeframe
Long Term (10+ years)

Market Size

Telehealth and remote diagnosis

Health Care
Health Care
Medical Technology

Expected Impact

Investments in telehealth models will improve access to healthcare services for the population as a whole and reduce the pressure on healthcare facilities, minimizing the risk of exposure for patients and healthcare workers during viral outbreaks.

Indicative Return
More than 25%

Investment Timeframe
Short Term (0–5 years)

PPE Production as a Response to COVID-19 Pandemic and Future Crises

Consumer Goods
Apparel and Textiles

Expected Impact

Investing in local businesses which manufacture disposable or washable face masks will create an efficient supply of PPEs for daily use and for health workers, reducing the risk of contagion during pandemics.

Indicative Return
15% – 20%

Investment Timeframe
Short Term (0–5 years)

Investing in Hospitals/Clinics to Provide Healthcare Services

Health Care Providers

Expected Impact

This IOA will increase access to high-quality healthcare services for the populations of neighboring countries.

Indicative Return
10% – 15%

Investment Timeframe
Medium Term (5–10 years)

Market Size

Wearable Medical Technologies for Better Health

Technology and Communications
Technology

Expected Impact

This IOA will facilitate early diagnosis and reduce the pressure on healthcare facilities, contributing positively to health and wellbeing indicators

Indicative Return
More than 25% > More than 25%

Investment Timeframe
Medium Term (5–10 years)

Market Size